bibliographic entry 5530308 [be/5530308]
https://w3id.org/oc/corpus/be/5530308

is a
content
  • Yeung DT, Vidovic L, Tang C, White DL, Branford S, Hughes TP et al. KIR2DL5B genotype independently predicts poor outcomes in CML-CP patients switched to nilotinib after suboptimal responses to imatinib and may refine prognosis in patients with EMR failure. Blood 2014; 124: 814–814.
references